Courtney Marabella | Authors


CASPIAN Update Shows Continued Benefit of Durvalumab/Chemotherapy in ES-SCLC

September 21, 2021

In patients with extensive-stage small cell lung cancer, durvalumab added to platinum/etoposide chemotherapy continued to demonstrate an overall survival improvement compared with chemotherapy alone with a favorable safety profile, according to updated data from the phase 3 CASPIAN trial.

Significant OS Benefit in Postmenopausal HR+/HER2- Advanced Breast Cancer Seen With Ribociclib/Letrozole Combo

September 19, 2021

In the first-line setting for postmenopausal patients with hormone receptor–positive, HER2-negative advanced breast cancer, the combination of ribociclib and letrozole demonstrated a statistically significant and clinically meaningful overall survival benefit compared with letrozole alone.

Regardless of Prior Antiandrogen Therapy in mHSPC, Enzalutamide/ADT Maintains Efficacy

September 12, 2021

Regardless of prior antiandrogen therapy and its pretreatment duration, enzalutamide plus androgen-deprivation therapy produced clinical benefit over ADT alone in patients with metastatic hormone-sensitive prostate cancer.